TRIM28 attenuates Bortezomib sensitivity of hepatocellular carcinoma cells through enhanced proteasome expression

• Jianchao Zhang,
• Xiaokai Fan,
• Lijuan Liao,
• Yan Zhu,
• Xiaochun Wan,
• Hai Rao,
• Liang Chen

Affiliations

Jianchao Zhang

Shenzhen Laboratory of Tumour Cell Biology Center for Protein and Cell‐based Drugs Institute of Biomedicine and Biotechnology Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Shenzhen China

Xiaokai Fan

Shenzhen Laboratory of Tumour Cell Biology Center for Protein and Cell‐based Drugs Institute of Biomedicine and Biotechnology Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Shenzhen China

Lijuan Liao

Shenzhen Laboratory of Tumour Cell Biology Center for Protein and Cell‐based Drugs Institute of Biomedicine and Biotechnology Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Shenzhen China

Yan Zhu

Shenzhen Laboratory of Tumour Cell Biology Center for Protein and Cell‐based Drugs Institute of Biomedicine and Biotechnology Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Shenzhen China

Xiaochun Wan

Shenzhen Laboratory of Tumour Cell Biology Center for Protein and Cell‐based Drugs Institute of Biomedicine and Biotechnology Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Shenzhen China

Hai Rao

Department of Biochemistry School of Medicine Southern University of Science and Technology Shenzhen China

Liang Chen

Shenzhen Laboratory of Tumour Cell Biology Center for Protein and Cell‐based Drugs Institute of Biomedicine and Biotechnology Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences Shenzhen China